Coherus Oncology
CHRS
CHRS
122 hedge funds and large institutions have $90.5M invested in Coherus Oncology in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
12% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 34
17% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 35
Holders
122
Holding in Top 10
–
Calls
$7.36M
Puts
$154K
Top Buyers
| 1 | +$7.29M | |
| 2 | +$1.79M | |
| 3 | +$1.77M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$739K |
| 5 |
Millennium Management
New York
|
+$348K |
Top Sellers
| 1 | -$7.09M | |
| 2 | -$2.99M | |
| 3 | -$2.97M | |
| 4 |
Goldman Sachs
New York
|
-$2.13M |
| 5 |
BlackRock
New York
|
-$1.21M |